Brown Advisory’s ARK Genomic Revolution ETF ARKG Stock Holding History

Brown Advisory’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,546	Closed	-$209K	–	1105
2022 Q1	$209K	Buy	4,546 +177	+4%	+$8.44K	﹤0.01%	1057
2021 Q4	$268K	Hold	4,369	–	–	﹤0.01%	1072
2021 Q3	$326K	Hold	4,369	–	–	﹤0.01%	921
2021 Q2	$404K	Hold	4,369	–	–	﹤0.01%	881
2021 Q1	$388K	Buy	+4,369	New	+$433K	﹤0.01%	891
2020 Q4	–	Sell	-4,049	Closed	-$258K	–	1017
2020 Q3	$258K	Buy	+4,049	New	+$237K	﹤0.01%	847

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Brown Advisory's ARKG Position: Q2 2022 in Review

Brown Advisory sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2022, closing a stake of 4,546 shares — an estimated $209K sold.

Brown Advisory first reported a position in ARKG in Q3 2020 and held it in 6 quarters. The position peaked at $404K in Q2 2021. 333 funds tracked by Wall St. Rank hold ARKG as of Q2 2022.

Brown Advisory reported no remaining ARK Genomic Revolution ETF position as of Q2 2022 after selling out during the quarter.
Brown Advisory sold 4,546 ARK Genomic Revolution ETF shares in Q2 2022, an estimated $209K.
Brown Advisory first reported a position in ARK Genomic Revolution ETF in Q3 2020 and held it in 6 quarters.
Brown Advisory's ARK Genomic Revolution ETF position peaked at $404K in Q2 2021.
333 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2022.

Based on Brown Advisory's 13F filing for Q2 2022, filed 2 Aug 2022.